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Abstract
Background: In this study, we investigated whether an abnormal hypothalamic-pituitary-adrenal (HPA) axis
response to psychosocial stress at 18 years of age is associated with musculoskeletal (MS) pain alone and MS pain
combined with increased pain sensitivity at 22 years of age.
Methods: The study sample included 805 participants from the Western Australian Pregnancy Cohort (Raine) Study
who participated in the Trier Social Stress Test (TSST) at age 18 years. Number of pain sites, pain duration, pain
intensity and pain frequency were assessed at age 22 to measure severity of MS pain. Cold and pressure pain
thresholds were determined at age 22. Group-based trajectory modeling was applied to establish cortisol response
patterns based on the TSST. Logistic regression was used to study the association of TSST patterns with MS pain
alone and MS pain combined with increased cold or pressure pain sensitivity, adjusted for relevant confounding
factors. All analyses were stratified by sex.
Results: The mean (standard deviation) age during the TSST was 18.3 (0.3) years, and during MS pain assessment it
was 22.2 (0.6). Forty-five percent of the participants were female. Three cortisol response patterns were identified,
with cluster 1 (34 % of females, 21 % of males) reflecting hyporesponse, cluster 2 (47 %, 54 %) reflecting
intermediate response and cluster 3 (18 %, 24 %) reflecting hyperresponse of the HPA axis. MS pain was reported
by 42 % of females and 33 % of males at age 22 years. Compared with females in cluster 2, females in cluster 1 had
an increased likelihood of having any MS pain (odds ratio 2.3, 95 % confidence interval 1.0–5.0) and more severe
MS pain (2.8, 1.1–6.8) if their cold pain threshold was above the median. In addition, females in cluster 1 had an
increased likelihood (3.5, 1.3–9.7) of having more severe MS pain if their pressure pain threshold was below the
median. No statistically significant associations were observed in males.
Conclusions: This study suggests that a hyporesponsive HPA axis at age 18 years is associated with MS pain at
22 years in young females with increased pain sensitivity.
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Background
Chronic musculoskeletal (MS) pain is a disabling
condition that occurs without an apparent tissue-level
pathology in several functional pain disorders [1]. Its
prevalence is higher among females and psychologically
stressed individuals [2]. Recent findings suggest a medi-
ating role of a major stress-regulating system, the
hypothalamic-pituitary-adrenal (HPA) axis, in the associ-
ation of stress with pain and pain hypersensitivity [3–5].
Several associations between variations in genes related
to both HPA axis and widespread MS pain have been
observed, emphasizing their potential link [6].
The HPA axis is a major system involved in the main-
tenance of homeostasis during stress, but it may develop
first hyper- and then hypoactivity in response to chronic
stress [7]. There is growing evidence that relative hypo-
cortisolism, as a marker of stress-induced HPA axis dys-
function, may in turn increase vulnerability to pain and
chronic pain disorders [5, 8–13]. In an experimental
study, pharmacologically induced hypocortisolism in-
creased mechanical pain sensitivity and potentiated
hyperalgesia in healthy males, suggesting that HPA axis
alterations have a causal role in pain [5]. In a cross-
sectional study of female twins, a blunted cortisol diur-
nal pattern was associated with higher perceived pain in-
tensity during a cold pressor test [13].
A cross-sectional population-based study found that
chronic multi-site MS pain was associated with lower
cortisol levels and a blunted diurnal cortisol pattern [8].
However, the same authors did not find an association
between HPA axis functioning and the onset of chronic
multi-site MS pain 6 years later [14]. Researchers in a
longitudinal study found that a flattened diurnal cortisol
profile and high post-dexamethasone cortisol levels pre-
dicted the onset of chronic multi-site MS pain 15 months
later among individuals with high somatization and
health-seeking behaviour [10].
Relative hypocortisolism may be present already in
early childhood in association with early-life stress and
psychopathology [15]. Similarly, chronic MS pain is re-
ported already in adolescence [16], implying that the dis-
order may also begin early in life in some individuals.
However, the association between HPA axis function
and MS pain is still unclear among adolescents and
young adults who are generally healthy and highly sensi-
tive to stress [17].
Therefore, the aim of this population-based study was
to investigate whether HPA axis response during acute
psychosocial stress at 18 years of age was associated with
subsequent MS pain presence and severity at age
22 years. In particular, we were interested in analysing
the association between cortisol responses with high
levels of MS pain in addition to high pain sensitivity. As
such, we performed two set of analyses to evaluate (1)
MS pain alone and (2) MS pain combined with increased
cold pain threshold (CPT) and decreased pressure pain
threshold (PPT). On the basis of previous research, we
hypothesized that (1) hyporeactive HPA axis at 18 years
would be associated with more severe MS pain at
22 years and (2) the association would be stronger in the
presence of relative cold and pressure pain hypersensitivity.
Methods
Study sample and data collection
The study sample was from the Western Australian
Pregnancy Cohort (Raine) Study, which includes chil-
dren of pregnant women enrolled in the study at or be-
fore the 18th gestation week between 1989 and 1992.
The original purpose of the study was to examine the ef-
fects of frequent and repeated ultrasound scans on preg-
nancy outcomes. The study is described in more detail
elsewhere [18]. The population-based cohort originally
included 2868 children who have been comprehensively
followed from birth to 22 years of age with multiple
follow-up points. The inclusion criteria of the study were
gestational age between 16 and 20 weeks, sufficient
English proficiency and an intention to remain in
Western Australia. The cohort has been shown to be
a socioeconomically representative sample of the
Western Australian population [19]. The Raine Study
ethical approval for the study was obtained from the
University of Western Australia Human Research Ethics
Committee (HREC), the Curtin University HREC for the
22-year-old cohort follow-up and the Princess Margaret
Hospital for Children HREC for the 17-year-old cohort
follow-up. Written informed consent was obtained from
all participants.
At 17 years of age, 1399 adolescents provided ques-
tionnaire data including physical activity level and de-
pressive symptoms, and measured height and weight
were also collected. At 18 years of age, 1137 individuals
participated in the Trier Social Stress Test (TSST); com-
pleted a questionnaire concerning illnesses, medication
use, smoking and oral contraceptive (OC) use; and had
their height and weight measured. Data on MS pain and
pain sensitivity were collected at 22 years of age, when
1138 cohort members answered the Örebro Musculo-
skeletal Pain Questionnaire and participated in clinical
assessments, including quantitative sensory testing. All
active cohort members were invited to participate in
each follow-up. The reason for nonparticipation at each
time point was primarily unwillingness to participate.
In total, 216 participants declined to have blood
collected during the TSST and 116 were excluded be-
cause of inability to complete the TSST (n = 2), un-
usable cortisol samples (n = 3), severe menstrual pain
(n = 1), pregnancy (n = 2), lactation (n = 2), type 1 diabetes
(n = 4), use of exogenous steroids (n = 7), neuroactive
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medications (n = 22), antidepressants (n = 19) or other
medications affecting the HPA axis (n = 2), non-
completion of the full test (n = 15) or having younger sib-
lings participating in the study (n = 37). After exclusions,
366 females and 439 males had complete data on plasma
total cortisol, and 277 females and 280 males had data on
both MS pain and cortisol. The number of individuals in-
cluded in the analysis varied from 198 to 222 among fe-
males (55 missing for covariates, 22 missing for cold pain
threshold and 24 missing for pressure pain threshold) and
from 198 to 215 among males (65 missing for covariates,
17 missing for cold pain threshold and 11 missing for
pressure pain threshold), as only individuals with
complete data on the measures of interest were included
in the analysis. Because this study involved three waves of
follow-up (at ages 17, 18 and 22 years), most of the miss-
ing data is due to participants choosing not to participate
in one or more of these follow-ups. The other cause was
incomplete data on the various questionnaires or tests.
Trier Social Stress Test
HPA axis function was evaluated by the TSST, which in-
cludes items assessing the essential features of a reliable
stressor being both uncontrollable and social-evaluative
[20, 21]. It is a highly standardized protocol to induce
psychological stress and cortisol response [20, 22]. The
subjects arrived at the hospital between 1200 h and
1600 h for the TSST. They were informed that eating
and/or drinking anything other than water within 1 h
before the test would affect stress hormone levels and
that therefore the test was to be conducted at least 1 h
after eating. Within 15 min after arrival, an anaesthetist
inserted an intravenous cannula after permission for tak-
ing blood samples was obtained. During the next 45-min
rest period, the participants completed a questionnaire,
and their height and weight were measured. After the
rest period, the participants performed a 15-min stress
test that included a free speech interview and an arith-
metic task in front of a non-responsive panel of two in-
terviewers and a dummy camera. In the debriefing
discussion afterwards, the goal of the study and the na-
ture of the stressor were explained to the participants. In
total, eight blood samples were taken: just preceding the
test (0 min); after completing the test (15 minutes); and
at 25, 35, 45, 60, 75 and 105 min.
Blood samples were collected in ethylenediaminetetra-
acetic acid tubes (BD Biosciences, San Jose, CA, USA)
and stored on ice during the test and were immediately
centrifuged, aliquoted and frozen at −80 °C after the test
until analyses. The GammaCoat™ Plasma Renin Activity
125I cortisol radioimmunoassay kit (DiaSorin, Stillwa-
ter, MN, USA) was used for quantifying total plasma
cortisol, and concentrations in micrograms per deci-
litre were converted to nanomoles per litre by
multiplying by 27.59. All assays were performed in
duplicate against a standard curve and repeated where
required. The intra- and inter-assay variability was ac-
ceptable (<10 %) for all assays.
Musculoskeletal pain
Pain status was evaluated using five items concerning
pain experience from the Örebro Musculoskeletal Pain
Questionnaire [23]; we did not use the full question-
naire, as it measures likelihood of developing a persistent
pain problem and related disability. The participants re-
ported whether they had current pain in the neck, left
and/or right shoulder, left and/or right arm, upper and/
or lower back, left and/or right leg or other site. They
were asked about the duration of their pain with ten an-
swer options varying from ‘0 days’ to ‘over 1 year’ that
were scored on a corresponding 0–9 scale. They were
asked about their pain intensity during the past week,
average pain intensity in the past 3 months and average
frequency of pain episodes during the past 3 months
with ten numerical answer options from ‘no pain’ or
‘never’ to ‘pain as bad as it could be’ or ‘always’ scored
on a corresponding 0–9 scale. A pain problem severity
index describing the severity of pain problems and vary-
ing from 0 to 37 was calculated by adding the following
scores: a sum of pain sites (0–10), pain duration (0–9),
mean of two pain intensity measures (0–9) and pain fre-
quency (0–9). Two dichotomous variables were derived
by categorizing subjects as follows: (1) no pain at all ver-
sus pain at any site and (2) pain problem severity index
above and below the 75th percentile.
Quantitative sensory testing
CPT and PPT were measured in a clinical setting
according to a standardized protocol [24]. CPT was
assessed using a Peltier element-based thermode with a
12.5-cm2 probe (Modular Sensory Analyser; Somedic
AB, Hörby, Sweden) applied on the skin of the dorsal
wrist. The baseline temperature was 32 °C, and the cut-
off minimum temperature limit was 5 °C. The rate of
temperature change was set to 1 °C/second, and the
stimulus was terminated when the subject pressed a but-
ton. The participants were given the following instruc-
tions: ‘Allow the temperature to drop until the moment
it reaches a point where it feels uncomfortably or pain-
fully cold, and then press the button. This means the
very first onset of discomfort or pain and not the most
cold that you can bear’. To measure PPT, an algometer
(Somedic AB, Farsta, Sweden) with a 1-cm2 contact head
was applied perpendicularly to the skin at four standard-
ized test sites in the following sequence: (1) dorsal wrist
(middle of the dorsal aspect of the wrist joint line), (2)
leg (the muscle belly of tibialis anterior, approximately
2.5 cm lateral and 5 cm distal to the tibial tubercle), (3)
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cervical spine (the trapezius muscle, at the mid-point be-
tween the C7 spinous process and the lateral acromion)
and (4) lumbar spine (at the erector spinae, 2 cm lateral
to the L4-L5 interspinous space). The pressure was in-
creased with a rate of 50 kPa/second, and the cut-off
maximum limit was 1000 kPa. The following instruc-
tions were given: ‘The moment the pressure increases to
a point where it first feels uncomfortable or painful,
press and release the button. This means the very first
onset of discomfort or pain and not the most pressure
that you can bear’. CPT and each PPT were tested four
times, and the mean threshold value of the last three
measurements was calculated (at most one missing value
allowed). The sex-specific median values were used as
cut-off points to identify individuals with increased pain
sensitivity [25]. CPT value above the median indicated
increased cold pain sensitivity, and an average of PPT
values at four different sites below the median indicated
increased pressure pain sensitivity.
Covariates
OC use, smoking, body mass index (BMI), physical ac-
tivity level and depressive symptoms were measured at
17 or 18 years of age and selected as covariates, as each
of them has been related to HPA axis function and MS
pain in previous studies [26–30]. OC use (yes or no) and
smoking (yes or no) were inquired about during the
TSST session and dichotomized into non-users vs. users
and current smokers vs. non-smokers. BMI was mea-
sured and calculated as weight (in kilograms) divided by
the square of body length (square meters) and catego-
rized into normal (BMI <25), overweight (25 ≥ BMI < 30)
and obese (BMI ≥30). If BMI at age 18 was missing,
height and weight data from 17 years of age were used
and BMI was categorized using the International Obesity
Task Force age-specific cut-off points [31]. Participation
in moderate to vigorous physical activity was measured
using the short-form International Physical Activity
Questionnaire [32]. As the association of physical activ-
ity with presence and severity of MS pain was U-shaped,
the study subjects were categorized into three groups:
(1) 0 h/week, (2) 0.1–4.9 h/week and (3) 5.0 h/week or
more. The Beck Depression Inventory was used to assess
depressive symptoms [33], and individuals were classi-
fied using the recommended cut-off values: minimal,
0–13; mild, 14–19; and moderate or severe, 20–63.
Statistical analyses
The cortisol data were analysed using the group-based
trajectory modeling (GBTM) approach, which is an
application of the finite mixture models for longitudinal
data [34]. The aim of GBTM is to identify the smallest
number of latent groups following different response pat-
terns, to which individuals are assigned probabilistically.
The selection of analytical method was based on the as-
sumption that there are distinct patterns of change in cor-
tisol levels over time. Specifically, in light of previous
findings and the allostatic load theory [4, 6], we antici-
pated identifying groups with atypical cortisol response
(i.e., with hypo- or hyper-reactive HPA axis). Our purpose
was to summarize the complex cortisol data in a parsimo-
nious manner, as done in previous studies with GBTM
using time-based cortisol data [35, 36].
As there are sex differences in pain and cortisol
responses, males and females were modelled separ-
ately [17, 26, 29]. The GBTM with one to five latent
groups was assessed in both sexes. The censored nor-
mal distribution was selected for the modelling after
transforming the cortisol values logarithmically. To
determine the number of groups that best represented
the data heterogeneity, the Bayesian information
criterion (BIC) was used; we also considered the prac-
tical value of the model with respect to the research
question, as recommended by Nagin and Odgers [37].
The χ2 test was used to compare the covariates used
in the multivariate models across the cortisol
response groups.
Logistic regression analysis was applied to model the
association between MS pain and cortisol response
groups, with adjustments made for all potentially con-
founding variables and stratification by sex. Only the in-
dividuals with full data on MS pain, cortisol and
covariates were included in the models. The association
was first analysed using (1) pain at any site or (2) pain
problem severity index above the 75th percentile as an
outcome variable, with the reference group including
those without or low severity of pain. In the next phase,
four composite outcomes were created in light of (1)
previous research in pain sensitivity testing, which does
not provide clear recommended cut-off values for CPT
or PPT for this age group; and (2) the need to identify
those participants with the most severe cases with suffi-
cient sample sizes in each subgroup; and (3) the need to
combine pain sensitivity and pain problem severity as an
outcome. The outcomes were (1) pain at any site and
CPT above the median, (2) pain at any site and PPT
below the median, (3) pain problem severity index above
the 75th percentile and CPT above the median and (4)
pain problem severity index above the 75th percentile
and PPT below the median. In the analyses regarding
composite variables, the reference group comprised
those without pain or with low severity of pain as well
as those with pain but with pain sensitivity below the
median. Previously, composite outcomes have been used
in the studies of, for example, cardiovascular, pulmonary
and gastrointestinal diseases [38], as well as in pain re-
search [39]. All analyses were performed using STATA
13.1 software (StataCorp, College Station, TX, USA).
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Results
The sample included 366 females and 439 males with a
mean (standard deviation [SD]) age of 18.3 (0.3) years
during the TSST and a mean age of 22.2 (0.6) during MS
pain assessment. The distributions of variables used in
the study are shown in the Table 1.
Musculoskeletal pain
MS pain at any site was reported by 42 % of females
and 33 % of males (Table 1). The pain problem sever-
ity indexes ranged from 0 to 33 among females and
from 0 to 29 among males, and the mean scores were
17 (SD 7) among females and 13 (SD 6) among males
having any MS pain. Females with a score of 15 or
more belonged to the highest quartile, whereas for
males the 75th percentile was 9, hereafter referred to
as high pain problem severity index. CPT was above
the median (females 15 °C or more, males 7 °C or
more) in 54 % of females and 48 % of males with any
pain, and in 59 % of females and 48 % of males with
a high pain problem severity index. PPT below the
median (females 318 kPa or less, males 419 kPa or
less) was found in 54 % of females and 45 % of males
with any pain and in 49 % of females and 47 % of
males with a high pain problem severity index.
Cortisol response groups
The three-group model was considered to fit the data
best in both sexes. It showed substantially lower BIC
values (i.e., a better fit) than the models with one or two
groups and the sizes of groups were reasonable provid-
ing meaningful interpretation of the data. Each individ-
ual had a high probability of belonging to their allocated
group, confirming model adequacy, with average poster-
ior probabilities being 0.97 for cluster 1, 0.97 for cluster
2, and 0.97 for cluster 3 among females, and 0.96, 0.97,
and 0.96 among males, respectively.
The mean baseline, peak and minimum cortisol
values over the study period were the highest in clus-
ter 3 (764/947/584 mmol/L, respectively, in females;
577/760/373 mmol/L, respectively, in males), followed
by cluster 2 (392/523/280 mmol/L, respectively; 344/
485/233 mmol/L, respectively) and cluster 1 (227/
295/152 mmol/L, respectively; 225/301/150 mmol/L,
respectively). Cluster 1, including 34 % of females and
21 % of males, had only a slight change in cortisol,
with small differences between baseline and peak
(difference between baseline and peak 68 mmol/L in
females, 76 mmol/L in males) (Figs. 1 and 2). Cluster
2, including 47 % of females and 54 % of males,
showed an immediate cortisol response followed by a
consistent return to baseline, and peak values differed
clearly from baseline (128 mmol/L, 140 mmol/L).
Cluster 3, including 18 % of females and 24 % of
Table 1 Distribution of variables used in the study
Females, n (%) Males, n (%)
Cortisol response group
Cluster 1 126 (34) 94 (21)
Cluster 2 173 (47) 238 (54)





No 324 (89) 355 (82)
Yes 41 (11) 79 (18)
Body mass index
Normal 261 (72) 313 (72)
Overweight 58 (16) 79 (18)
Obese 43 (12) 41 (10)
Physical activity level
0 h/wk 139 (45) 108 (32)
0.1–4.9 h/wk 112 (37) 114 (34)
≥ 5.0 h/wk 56 (18) 117 (35)
Depressive symptoms
Minimal 219 (72) 309 (86)
Mild 42 (14) 33 (9)
Moderate to severe 42 (14) 16 (5)
MS pain
No 160 (58) 188 (67)
Yes 117 (42) 92 (33)
MS pain and CPT > P50a
No 193 (77) 218 (85)
Yes 57 (23) 37 (15)
MS pain and PPT < P50b
No 189 (76) 227 (86)
Yes 59 (24) 37 (14)
Pain problem severity indexc
Low 204 (74) 210 (75)
Highc 73 (26) 70 (25)
High painc and CPT > P50a
No 215 (86) 228 (89)
Yes 35 (14) 27 (11)
High painc and PPT < P50b
No 219 (88) 235 (89)
Yes 29 (12) 29 (11)
MS musculoskeletal, CPT cold pain threshold, PPT pressure pain threshold
aMedian (P50) CPT = 15 °C in females and 7 °C in males
bMedian (P50) PPT = 318 kPa in females and 419 kPa in males
cHigh pain problem severity index = 15 or more in females and 9 or more
in males
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males, displayed a substantial response with a large
variation in cortisol values between baseline and peak
(178 mmol/L, 183 mmol/L).
Cluster 3 included significantly more females using
OC (87 %) than cluster 2 (39 %) or cluster 1 (11 %)
(p < 0.001) (Table 2). Males with a high physical activity
level were underrepresented in cluster 3 (p = 0.048), and a
similar but statistically non-significant trend was seen
among females (p = 0.090). Obesity (p = 0.073) and smok-
ing (p = 0.085) tended to be associated with being in clus-
ter 1 among females, but these associations were not
statistically significant. Also, there were no significant
differences in depressive symptoms across the cortisol re-
sponse groups.
Association between cortisol response and MS pain
Compared with cluster 2, belonging to cluster 1 or
cluster 3 (i.e., cortisol hypo- or hyper-responsiveness)
was not associated with any MS pain or a high pain
problem severity index in either females or males
(Tables 3 and 4). The females in cluster 1 demonstrated
a significant association with any MS pain (odds ratio
2.3, 95 % confidence interval 1.0–5.0) and with high pain
problem severity index (2.8, 1.1–6.8) if CPT was above
the median. The females in cluster 1 also had an in-
creased likelihood of a high pain problem severity index
if PPT was below the median (3.5, 1.3–9.7), whereas any
MS pain in combination with PPT below the median
showed only a borderline significant association (2.2,
1.0–4.8). Among males, all associations remained statis-
tically non-significant (Table 4).
Discussion
In this study, in females with pain sensitivity measures
above the 50th percentile, a hypoactive HPA axis at age
18 years was associated with both the presence and the
severity of pain problems at 22 years. This was evi-
denced by cluster 1 displaying higher odds than cluster 2
for pain presence and pain problem severity in those
with higher cold pain sensitivity, as well as higher odds
for pain problems in those with higher pressure pain
sensitivity. The associations were independent of the ef-
fects of OC use, smoking, BMI, physical activity level
and depressive symptoms.
Our study is the first analysis of the association be-
tween HPA axis stress response and MS pain in young
adults. It was conducted in a representative birth cohort
and had a longitudinal design with a 4-year follow-up.
Cortisol stress response was measured under controlled
conditions using a previously established protocol [20].
Cortisol responses to laboratory stress correlated strongly
with total cortisol over the day, but not with cortisol awak-
ening response or cortisol slope in a recent study [40]. In
this respect, we believe that our cortisol response groups,
although based on response during short-term stimuli,
reflected the volume of cortisol secretion in repeated
real-life stress.
Using GBTM, we identified three groups showing
different cortisol stress responses in young males and fe-
males. In a recent study, researchers applied the same
statistical method with four saliva cortisol samples col-
lected from a group of adolescent females during the
TSST [34]. They found normative (59 %), hyporespon-
sive (27 %) and hyperresponsive (15 %) groups, which
corresponds well with our results. Van Ryzin et al. used
GBTM with diurnal cortisol data among preschool chil-
dren [35] and also found two atypical cortisol patterns
(i.e., a hyper-cortisol group [10 %] and a hypo-cortisol
group [16 %]) in addition to a normative group (74 %).
In the majority of TSST studies, investigators have used
raw cortisol values or calculated area under curve pa-
rameters, and have applied the traditional statistical



















Fig. 1 Actual cortisol values in different cortisol response groups
in females



















Fig. 2 Actual cortisol values in different cortisol response groups
in males
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techniques [11, 12]. These methods assume sample
homogeneity with respect to change over time, whereas
underlying subgroups representing different patterns of
change can be captured with the group-based trajectory
approach [37].
Our findings are broadly in line with previous studies
linking HPA axis dysfunction with MS pain [8–12] and
increased pain sensitivity [5, 13]. To our knowledge,
there are only a few previous studies on the relationship
between cortisol response in the TSST and MS pain [11,
12]. One study showed decreased salivary cortisol levels
after awakening but not during the TSST among adoles-
cents with overtiredness, dizziness and MS pain [12].
However, the association of MS pain and cortisol levels
was not analysed separately from other symptoms, and
the TSST was preceded by other potentially stressful
tasks. In a small-scale study, middle-aged patients with
fibromyalgia showed significantly reduced plasma corti-
sol response during the TSST, supporting our findings
[11]. A flattened diurnal cortisol profile predicted new-
onset widespread pain among individuals with high
somatization and health-seeking behaviour in a British
study [10], and another population-based study also
showed that chronic multi-site MS pain was associated
with lower cortisol levels and blunted diurnal slope [8].
The researchers in these two studies did not analyse
stress-related cortisol levels, however, and the findings
are not directly comparable to ours. In one study, re-
searchers did not detect an association between 24-h
urinary free cortisol and functional MS symptoms [41].
Interestingly, we found that a hyporesponsive HPA
axis was significantly associated with MS pain in females
only in combination with increased pain sensitivity. A
population-based sample of young adults with MS pain
is likely to be heterogeneous, with some having injury-
or disease-related pain and others with more non-
specific symptoms. Relative hypocortisolism may explain
pain in certain subgroups by enhancing both central and
peripheral sensitization of pain pathways by increased
pro-inflammatory activity [42, 43]. Among patients
with back pain, increased levels of pro-inflammatory
cytokines together with a hyporesponsive HPA axis
predicted failure in surgery [9], whereas patients with
chronic widespread pain showed lower levels of Th2
anti-inflammatory cytokines than controls [44]. Pro-
inflammatory cytokines may activate’ a sickness re-
sponse’, which is believed to explain typical symptoms
in functional pain syndromes, including exaggerated
pain sensitivity [43]. This potential underlying mech-
anism supports our results, assuming that pain hyper-
sensitivity is a marker of sensitization of the nervous
system.
We did not find any association between HPA axis
function and MS pain in males. Previous studies have
Table 2 Descriptive statistics for covariates according to cortisol response groups
Females, n (%) Males, n (%)
Cluster 1 Cluster 2 Cluster 3 p Valuea Cluster 1 Cluster 2 Cluster 3 p Valuea
Oral contraceptive use <0.001
No 112 (89) 106 (61) 9 (13)
Yes 14 (11) 67 (39) 58 (87)
Smoking 0.085 0.300
No 107 (85) 153 (89) 64 (96) 74 (79) 190 (81) 91 (87)
Yes 19 (15) 19 (11) 3 (5) 20 (21) 45 (19) 14 (13)
Body mass index 0.073 0.955
Normal 83 (67) 128 (74) 50 (76) 67 (73) 171 (73) 75 (71)
Overweight 18 (15) 28 (16) 12 (18) 16 (17) 41 (18) 22 (21)
Obese 23 (19) 16 (9) 4 (6) 9 (10) 23 (10) 9 (9)
Physical activity level 0.090 0.048
0 h/wk 50 (48) 57 (40) 32 (53) 26 (38) 49 (27) 33 (38)
0.1–4.9 h/wk 31 (30) 57 (40) 24 (39) 18 (26) 63 (34) 33 (38)
≥ 5.0 h/wk 23 (22) 28 (20) 5 (8) 25 (36) 72 (39) 20 (23)
Depressive symptoms 0.393 0.167
Minimal 73 (70) 103 (73) 43 (75) 68 (91) 171 (86) 70 (82)
Mild 12 (11) 22 (16) 8 (14) 2 (3) 20 (10) 11 (13)
Moderate to severe 20 (19) 16 (11) 6 (11) 5 (7) 7 (4) 4 (5)
ap Values derived from χ2 test
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reported that, compared with males, females have more
chronic pain disorders [1], a lower pain threshold [25]
and a lower cortisol response to stress [45]. In our study,
cluster 1 had a higher proportion of females (34 %) than
males (21 %), and females showed lower cortisol values
during the TSST than males after controlling for OC use
(data not shown). This lower cortisol response, as a sign
of relative hypocortisolism, observed in females more
often than males may contribute to the higher preva-
lence of pain disorders in females [45], and also explains
why we did not find a significant association in males.
The sex hormones may have a role in the reported dif-
ferences between sexes [45]. Oestradiol has been shown
to induce HPA axis stimulation [46] and also to improve
pain perception [47]. Although females generally show
lower HPA axis response to stress than males of the
same age [45], the response during the luteal menstrual
phase (high oestrogen level) is higher than during the
follicular phase (low oestrogen level) and is comparable
to that of males [48]. An explanation for our findings of
sex differences warrants further studies controlling for
menstrual cycle phase.
An important limitation of our study is that we did
not have information about menstrual cycle phase,
which may potentially confound the results. Variation in
oestrogen levels influencing cortisol binding capacity is
likely to explain intra- and inter-individual differences
among females [28], such as our finding that OC use is
associated with a higher total plasma cortisol response
in the TSST. We were not able to analyse females on
OC separately, owing to sample size restrictions. As ex-
cluding females on OC did not change the overall results
Table 3 Multivariate logistic regression analysis for variables associated with musculoskeletal pain alone and combined with
increased pain sensitivity among females
MS pain only MS pain combined with CPT > P50a MS pain combined with PPT < P50a
Any pain High pain problem
severityb
Any pain High pain problem
severityb
Any pain High pain problem
severityb
Cortisol response group
Cluster 1 1.5 (0.8–2.8) 1.8 (0.9–3.7) 2.3 (1.0–5.0)c 2.8 (1.1–6.8)c 2.2 (1.0–4.8) 3.5 (1.3–9.7)c
Cluster 2 1.0 1.0 1.0 1.0 1.0 1.0
Cluster 3 0.6 (0.3–1.4) 1.1 (0.4–2.8) 0.9 (0.3–2.7) 1.5 (0.4–5.5) 0.8 (0.3–2.6) 1.7 (0.3–8.2)
Oral contraceptive use
No 1.0 1.0 1.0 1.0 1.0 1.0
Yes 1.3 (0.7–2.5) 1.0 (0.5–2.1) 0.8 (0.4–2.0) 0.6 (0.2–1.8) 0.8 (0.3–1.9) 0.4 (0.1–1.4)
Smoking
No 1.0 1.0 1.0 1.0 1.0 1.0
Yes 0.9 (0.3–2.9) 1.6 (0.5–5.3) 0.7 (0.1–3.6) 1.1 (0.2–6.2) 0.2 (0.0–1.9) 0.7 (0.1–6.7)
Body mass index
Normal 1.0 1.0 1.0 1.0 1.0 1.0
Overweight 1.2 (0.6–2.6) 1.3 (0.6–2.9) 0.6 (0.2–1.6) 0.7 (0.2–2.2) 0.4 (0.1–1.3) 0.9 (0.3–3.1)
Obese 1.3 (0.4–3.6) 0.6 (0.2–1.9) 0.7 (0.2–2.5) 0.4 (0.1–2.1) 0.6 (0.2–2.3) 0.2 (0.0–2.0)
Physical activity level
0 h/wk 1.0 1.0 1.0 1.0 1.0 1.0
0.1–4.9 h/wk 1.1 (0.6–2.1) 1.3 (0.6–2.5) 1.0 (0.5–2.1) 1.1 (0.4–2.5) 0.7 (0.3–1.5) 0.6 (0.2–1.7)
≥ 5.0 h/wk 0.8 (0.4–1.6) 0.8 (0.3–2.0) 0.5 (0.2–1.3) 0.7 (0.2–2.0) 0.3 (0.1–0.8) 0.3 (0.1–1.2)
Depressive symptoms
Minimal 1.0 1.0 1.0 1.0 1.0 1.0
Mild 1.8 (0.9–3.9) 1.7 (0.7–3.7) 2.0 (0.8–4.8) 1.9 (0.7–5.2) 2.0 (0.8–5.0) 1.0 (0.3–3.5)
Moderate to severe 1.3 (0.5–3.0) 1.7 (0.7–4.3) 0.7 (0.2–2.1) 0.8 (0.2–2.9) 0.9 (0.3–2.6) 0.6 (0.2–2.5)
MS musculoskeletal, CPT cold pain threshold, PPT pressure pain threshold
Data are presented as odds ratios with 95 % confidence intervals
aMedian (P50) CPT = 15 °C; median PPT = 318 kPa
bHigh pain problem severity index = 15 or more
cp < 0.05
All covariates were included in the multivariate model. Reference group includes those without pain or with a low severity of pain and those with pain but with
CPT < P50 or PPT > P50
The number of individuals included in the analysis varied from 198 to 222 due to missing data
Paananen et al. Arthritis Research & Therapy  (2015) 17:355 Page 8 of 11
(non-reported data), however, all females were analysed
together. As cortisol values were higher at the beginning
than at the end of the TSST in all response groups, a
start point of HPA axis activation and true baseline
values cannot be determined. Although cluster 1 and 3
were interpreted as hyporesponsive and hyperresponsive,
we cannot exclude that the groups reflect different
baseline levels rather than differential responsiveness.
Unfortunately, we did not have subjective or objective
measures of stress related to anticipation or cannulation
during the rest phase, nor did we have previous data on
baseline cortisol levels.
Potential fluctuation of HPA axis function over an
extended time remains unclear. The TSST has been
performed on only one occasion in the Raine cohort.
HPA axis hyporeactivity appeared stable over 12 months
among women with depression, with authors of this par-
ticular study suggesting that cortisol hyporesponse may
be a trait marker [49]. During childhood and adoles-
cence, the long-term stability of HPA axis function in
stress has been shown to be at least mild to moderate
[50, 51], potentially supporting this view. However, while
we consider that HPA axis function at 18 years of age
may be related to a pro-nociceptive state that increases
the potential for altered pain sensitivity and MS pain
later in life, stability of HPA axis function over time may
moderate this assumption. Another limitation is that we
did not assess pain status or pain thresholds at baseline,
leaving their course unknown. Consequently, we could
not explicitly determine the causality of the observed
associations (i.e., whether HPA axis dysfunction was a cause
rather than a biomarker of MS pain). Future research using
multiple measures of cortisol and MS pain over time is
required to further test the validity of our results.
Our measure of pain problem severity was limited to
five questions derived from the well-validated Örebro
Musculoskeletal Pain Questionnaire, and we believe it
demonstrates face validity as it includes multiple facets
of a pain problem. However, we acknowledge that this
measure has not previously been used or validated
against other more established measures of the severity
of pain conditions. We were not able to test cut-off
Table 4 Multivariate logistic regression analysis for variables associated with musculoskeletal pain alone and combined with
increased pain sensitivity among males
MS pain only MS pain combined with CPT > P50a MS pain combined with PPT < P50a
Any pain High pain problem
severityb
Any pain High pain problem
severityb
Any pain High pain problem
severityb
Cortisol response group
Cluster 1 0.7 (0.3–1.5) 0.6 (0.3–1.5) 1.2 (0.4–3.3) 1.6 (0.5–4.9) 1.5 (0.6–4.1) 1.7 (0.6–4.9)
Cluster 2 1.0 1.0 1.0 1.0 1.0 1.0
Cluster 3 0.9 (0.4–1.8) 0.8 (0.3–1.8) 1.0 (0.4–2.9) 1.2 (0.3–3.9) 2.1 (0.9–5.4) 2.1 (0.7–5.9)
Smoking
No 1.0 1.0 1.0 1.0 1.0 1.0
Yes 1.1 (0.4–2.8) 1.7 (0.6–4.4) 0.2 (0.0–1.9) 0.3 (0.0–2.9) 0.6 (0.1–2.8) 0.7 (0.2–3.7)
Body mass index
Normal 1.0 1.0 1.0 1.0 1.0 1.0
Overweight 1.5 (0.7–3.0) 1.8 (0.8–3.8) 0.9 (0.3–2.6) 1.1 (0.4–3.6) 0.7 (0.3–2.0) 1.0 (0.3–3.1)
Obese 1.7 (0.5–6.2) 2.9 (0.8–10.8) 1.1 (0.1–9.5) 1.6 (0.2–15.8) 1.5 (0.3–7.7) 2.2 (0.4–11.7)
Physical activity level
0 h/wk 1.0 1.0 1.0 1.0 1.0 1.0
0.1–4.9 h/wk 0.7 (0.3–1.4) 0.4 (0.2–1.0) 0.4 (0.1–1.3) 0.3 (0.1–1.2) 0.8 (0.3–2.1) 0.6 (0.2–1.8)
≥ 5.0 h/wk 1.0 (0.5–2.1) 0.8 (0.4–1.8) 0.8 (0.3–2.0) 0.8 (0.3–2.4) 0.8 (0.3–2.1) 0.9 (0.3–2.5)
Depressive symptoms
Minimal 1.0 1.0 1.0 1.0 1.0 1.0
Mild 1.4 (0.5–4.2) 1.6 (0.5–4.9) 3.1 (0.9–10.8) 3.3 (0.9–12.8) 1.4 (0.3–5.5) 1.8 (0.4–7.5)
Moderate to severe 4.2 (1.0–17.9) 3.7 (0.9–15.3) 1.2 (0.1–10.9) 1.5 (0.2–15.2) 0.7 (0.1–6.4) 0.9 (0.1–8.4)
MS musculoskeletal, CPT cold pain threshold, PPT pressure pain threshold
Data are presented as odds ratios with 95 % confidence intervals
aMedian (P50) CPT = 7 °C; median PPT = 419 kPa
bHigh pain problem severity index = 9 or more
All covariates were included in the multivariate model. Reference group includes those without pain or with a low severity of pain and those with pain but with
CPT < P50 or PPT > P50
The number of individuals included in the analysis varied from 198 to 215 due to missing data
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values other than the median for pain thresholds, be-
cause sample sizes in each subgroup would have become
too small. Finally, due to the large number of partici-
pants, we were restricted to capture of pain thresholds
only, without using dynamic tests of pain sensitivity,
which presents a somewhat limited assessment of the
pain-processing system [52].
Conclusions
We identified that a hyporesponsive HPA axis at 18 years
of age is associated with MS pain at age 22 years in
young adults. However, the association between cortisol
stress response and MS pain was found only in females
and when pain was related to increased pain sensitivity.
In the future, studies with longitudinal cortisol data and
MS pain would be useful to further elucidate the nature
of the relationship between HPA axis function and MS
pain, including the sex discrepancy.
Abbreviations
BIC: Bayesian information criterion; BMI: body mass index; CPT: cold pain
threshold; GBTM: group-based trajectory modelling; HPA: hypothalamic-
pituitary-adrenal; HREC: human research ethics committee;
MS: musculoskeletal; OC: oral contraceptive; PPT: pressure pain threshold;
SD: standard deviation; TSST: Trier Social Stress Test.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MP, PO, LS, DB, PC, JK, CP and AS participated in study conception and design
and contributed to the writing of the manuscript. MP was responsible for the
literature review. POS, LS, DB, CP and AS were involved in data collection. MP
and AS performed statistical analyses. MP drafted the first manuscript. All the
authors meet the criteria for authorship, and all read and approved the final
manuscript.
Acknowledgements
The authors thank the Raine Study participants for their ongoing
participation in the study; the Raine Study Team for study co-ordination and
data collection. The authors also thank the following entities for providing
funding for the Core Management of the Raine Study: the UWA Centre for
Science for use of the facility; the University of Western Australia (UWA); the
Raine Medical Research Foundation; the UWA Faculty of Medicine, Dentistry
and Health Sciences; the Telethon Kids Institute; the Women’s and Infant’s
Research Foundation (KEMH); Curtin University; and Edith Cowan University.
The 22-year Raine Study follow-up was funded by National Health and
Medical Research Council (NHMRC) project grants 1027449, 1044840 and
1021855. Funding was also provided by Safe Work Australia. The TSST was
funded by the Canadian Institutes of Health Research (Lye et al., grant
MOP-82893), and the 17-year follow-up was supported by an NHMRC
program grant (Stanley et al., grant 353514). MP was supported by the
Emil Aaltonen Foundation, the Signe and Ane Gyllenberg Foundation
and the Finnish Association for the Study of Pain. JK was supported by
the Yrjö Jahnsson Foundation. DB and LS were supported by research
fellowships from the NHMRC of Australia.
Author details
1Centre for Life Course Epidemiology, and Medical Research Centre Oulu,
Oulu University Hospital and University of Oulu, Oulu, Finland. 2School of
Physiotherapy and Exercise Science, Curtin University, Perth, Australia.
3Centre of Expertise for Health and Work Ability and Disability Prevention
Centre, Finnish Institute of Occupational Health, Oulu, Finland. 4School of
Women’s and Infants’ Health, The University of Western Australia, Perth,
Australia.
Received: 17 May 2015 Accepted: 25 November 2015
References
1. Aaron LA, Buchwald D. Chronic diffuse musculoskeletal pain, fibromyalgia
and co-morbid unexplained clinical conditions. Best Pract Res Clin
Rheumatol. 2003;17:563–74.
2. McBeth J, Jones K. Epidemiology of chronic musculoskeletal pain. Best Pract
Res Clin Rheumatol. 2007;21:403–25.
3. Van Houdenhove B, Luyten P. Central sensitivity syndromes: stress system
failure may explain the whole picture. Semin Arthritis Rheum.
2009;39:218–9.
4. Crettaz B, Marziniak M, Willeke P, Young P, Hellhammer D, Stumpf A,
et al. Stress-induced allodynia–evidence of increased pain sensitivity
in healthy humans and patients with chronic pain after
experimentally induced psychosocial stress. PLoS One.
2013;8:e69460.
5. Kuehl LK, Michaux GP, Richter S, Schanchinger H, Anton F. Increased basal
mechanical pain sensitivity but decreased perceptual wind-up in a human
model of relative hypocortisolism. Pain. 2010;149:539–46.
6. Kl H, Nicholl BI, Macfarlane GJ, Thomson W, Davies KA, McBeth J. Genetic
variation in the hypothalamic-pituitary-adrenal stress axis influences
susceptibility to musculoskeletal pain: results from the EPIFUND study. Ann
Rheum Dis. 2010;69:556–60.
7. Miller GE, Chen E, Zhou ES. If it goes up, must it come down? Chronic stress
and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull.
2007;133:25–45.
8. Generaal E, Vogelzangs N, Macfarlane GJ, Geenen R, Smit JH, Penninx BW,
et al. Reduced hypothalamic-pituitary-adrenal axis activity in chronic
multi-site musculoskeletal pain: partly masked by depressive and anxiety
disorders. BMC Musculoskelet Disord. 2014;15:227.
9. Geiss A, Rohleder N, Kirschbaum C, Steinbach K, Bauer HW, Anton F.
Predicting the failure of disc surgery by a hypofunctional HPA axis: evidence
from a prospective study on patients undergoing disc surgery. Pain.
2005;114:104–17.
10. McBeth J, Silman AJ, Gupta A, Chiu YH, Ray D, Morriss R, et al. Moderation
of psychosocial risk factors through dysfunction of the hypothalamic-
pituitary-adrenal stress axis in the onset of chronic widespread
musculoskeletal pain: findings of a population-based prospective cohort
study. Arthritis Rheum. 2007;56:360–71.
11. Wingenfeld K, Heim C, Schmidt I, Wagner D, Meinlschmidt G, Hellhammer
DH. HPA axis reactivity and lymphocyte glucocorticoid sensitivity in
fibromyalgia syndrome and chronic pelvic pain. Psychosom Med.
2008;70:65–72.
12. Janssens KA, Oldehinkel AJ, Verhulst FC, Hunfeld JA, Ormel J, Rosmalen JG.
Symptom-specific associations between low cortisol responses and
functional somatic symptoms: the TRAILS study. Psychoneuroendocrinology.
2012;37:332–40.
13. Godfrey KM, Strachan E, Dansie E, Crofford LJ, Buchwald D, Goldberg J, et al.
Salivary cortisol and cold pain sensitivity in female twins. Ann Behav Med.
2014;47:180–8.
14. Generaal E, Vogelzangs N, Macfarlane GJ, Geenen R, Smit JH, de Geus EJ,
et al. Biological stress systems, adverse life events and the onset of chronic
multisite musculoskeletal pain: a 6-year cohort study. Ann Rheum Dis. doi:
10.1136/annrheumdis-2014-206741.
15. Badanes LS, Watamura SE, Hankin BL. Hypocortisolism as a potential marker
of allostatic load in children: associations with family risk and internalizing
disorders. Dev Psychopathol. 2011;23:881–96.
16. Hoftun GB, Romundstad PR, Zwart JA, Rygg M. Prevalence of chronic
idiopathic musculoskeletal pain and headache in adolescence: a
population based Norwegian study [poster]. Pediatr Rheumatol Online
J. 2012;10 Suppl 1:A77.
17. Lupien SJ, McEwen BS, Gunnar MR, Heim C. Effects of stress throughout the
lifespan on the brain, behaviour and cognition. Nat Rev Neurosci.
2009;10:434–45.
18. Williams LA, Evans SF, Newnham JP. Prospective cohort study of factors
influencing the relative weights of the placenta and the newborn infant.
BMJ. 1997;314:1864–8.
19. O’Sullivan PB, Beales DJ, Smith AJ, Straker LM. Low back pain in 17 year olds
has substantial impact and represents an important public health disorder:
a cross-sectional study. BMC Public Health. 2012;12:100.
Paananen et al. Arthritis Research & Therapy  (2015) 17:355 Page 10 of 11
20. Kirschbaum C, Pirke KM, Hellhammer DH. The ‘Trier Social Stress Test’–a tool
for investigating psychobiological stress responses in a laboratory setting.
Neuropsychobiology. 1993;28:76–81.
21. Dickerson SS, Kemeny ME. Acute stressors and cortisol responses: a
theoretical integration and synthesis of laboratory research. Psychol Bull.
2004;130:355–91.
22. Foley P, Kirschbaum C. Human hypothalamus-pituitary-adrenal axis
responses to acute psychosocial stress in laboratory settings. Neurosci
Biobehav Rev. 2010;35:91–6.
23. Linton SJ, Boersma K. Early identification of patients at risk of developing a
persistent back problem: the predictive validity of the Örebro
Musculoskeletal Pain Questionnaire. Clin J Pain. 2003;19:80–6.
24. Rolke R, Baron R, Maier C, Tölle TR, Treede RD, Beyer A, et al. Quantitative
sensory testing in the German Research Network on Neuropathic Pain
(DFNS): standardized protocol and reference values. Pain. 2006;123:231–43.
25. Chesterton LS, Barlas P, Foster NE, Baxter GD, Wright CC. Gender differences
in pressure pain threshold in healthy humans. Pain. 2003;101:259–66.
26. Paananen M, Auvinen J, Taimela S, Tammelin T, Kantomaa M, Ebeling H,
et al. Psychosocial, mechanical, and metabolic factors in adolescents’
musculoskeletal pain in multiple locations: a cross-sectional study. Eur J
Pain. 2010;14:395–401.
27. Wijnhoven HA, de Vet HC, Smit HA, Picavet HS. Hormonal and reproductive
factors are associated with chronic low back pain and chronic upper
extremity pain in women–the MORGEN study. Spine. 2006;31:1496–502.
28. Gaffey AE, Wirth MM, Hoks RM, Jahn AL, Abercrombie HC. Circulating
cortisol levels after exogenous cortisol administration are higher in women
using hormonal contraceptives: data from two preliminary studies. Stress.
2004;17:314–20.
29. Kudielka BM, Wüst S. Human models in acute and chronic stress: assessing
determinants of individual hypothalamus-pituitary-adrenal axis activity and
reactivity. Stress. 2010;13:1–14.
30. Rimmele U, Zellweger BC, Marti B, Seiler R, Mohiyeddini C, Ehlert U, et al.
Trained men show lower cortisol, heart rate and psychological responses to
psychosocial stress compared with untrained men.
Psychoneuroendocrinology. 2007;32:627–35.
31. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition
for child overweight and obesity worldwide: international survey. BMJ.
2000;320:1240–3.
32. Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE.
International physical activity questionnaire: 12-country reliability and
validity. Med Sci Sports Exerc. 2003;35:1381–95.
33. Beck AT, Beamesderfer A. Assessment of depression: the depression
inventory. Mod Probl Pharmacopsychiatry. 1974;7:151–69.
34. Nagin DS. Group-based modeling of development. Cambridge, MA: Harvard
University Press; 2005.
35. Van Ryzin MJ, Chatham M, Kryzer E, Kertes DA, Gunnar MR. Identifying
atypical cortisol patterns in young children: the benefits of group-based
trajectory modeling. Psychoneuroendocrinology. 2009;34:50–61.
36. Giletta M, Calhoun CD, Hastings PD, Rudolph KD, Nock MK, Prinstein MJ.
Multi-level risk factors for suicidal ideation among at-risk adolescent
females: the role of hypothalamic-pituitary-adrenal axis responses to stress. J
Abnorm Child Psychol. 2015;43:807–20.
37. Nagin DS, Odgers CL. Group-based trajectory modeling in clinical research.
Annu Rev Clin Psychol. 2010;6:109–38.
38. Goldberg R, Gore JM, Barton B, Gurwitz J. Individual and composite study
endpoints: separating the wheat from the chaff. Am J Med.
2014;127:379–84.
39. Moulin DE, Clark AJ, Gordon A, Lynch M, Morley-Forster PK, Nathan H, et al.
Long-term outcome of the management of chronic neuropathic pain: a
prospective observational study. J Pain. 2015;16:852–61.
40. Kidd T, Carvalho LA, Steptoe A. The relationship between cortisol responses
to laboratory stress and cortisol profiles in daily life. Biol Psychol.
2014;99:34–40.
41. Tak LM, Bakker SJ, Rosmalen JG. Dysfunction of the hypothalamic-pituitary-
adrenal axis and functional somatic symptoms: a longitudinal cohort study
in the general population. Psychoneuroendocrinology. 2009;34:869–77.
42. Chrousos GP. Stress, chronic inflammation, and emotional and physical
well-being: concurrent effects and chronic sequelae. J Allergy Clin Immunol.
2000;106(5 Suppl):S275–91.
43. Wieseler-Frank J, Maier SF, Watkins LR. Central proinflammatory cytokines
and pain enhancement. Neurosignals. 2005;14:166–74.
44. Uçeyler N, Valenza R, Stock M, Schedel R, Sprotte G, Sommer C. Reduced
levels of antiinflammatory cytokines in patients with chronic widespread
pain. Arthritis Rheum. 2006;54:2656–64.
45. Kudielka BM, Kirschbaum C. Sex differences in HPA axis responses to stress:
a review. Biol Psychol. 2005;69:113–32.
46. Kirschbaum C, Schommer N, Federenko I, Gaab J, Neumann O, Oellers M,
et al. Short-term estradiol treatment enhances pituitary adrenal axis and
sympathetic responses to psychosocial stress in healthy young men. J Clin
Endocrinol Metab. 1996;81:3639–43.
47. Rezaii T, Hirschberg AL, Carlström K, Ernberg M. The influence of menstrual
cycle phases on pain modulation in healthy women. J Pain. 2012;13:646–55.
48. Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH. Impact
of gender, menstrual cycle phase, and oral contraceptives on the activity of
the hypothalamus-pituitary-adrenal axis. Psychosom Med. 1999;61:154–62.
49. Wahlberg K, Ghatan PH, Modell S, Nygren A, Ingvar M, Asberg M, et al.
Suppressed neuroendocrine stress response in depressed women on
job-stress-related long-term sick leave: a stable marker potentially
suggestive of preexisting vulnerability. Biol Psychiatry. 2009;65:742–7.
50. Hankin BL, Badanes LS, Smolen A, Young JF. Cortisol reactivity to stress
among youth: stability over time and genetic variants for stress sensitivity.
J Abnorm Psychol. 2015;124:54–67.
51. Platje E, Vermeiren RR, Branje SJ, Doreleijers TA, Meeus WH, Koot HM, et al.
Long-term stability of the cortisol awakening response over adolescence.
Psychoneuroendocrinology. 2013;38:271–80.
52. Arendt-Nielsen L, Yarnitsky D. Experimental and clinical applications of
quantitative sensory testing applied to skin, muscles and viscera. J Pain.
2009;10:556–72.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Paananen et al. Arthritis Research & Therapy  (2015) 17:355 Page 11 of 11
